Management of dabigatran-induced bleeding: expert statement

Autor:	Andreas Pachucki, Heinrich W. Thaler, Barbara Steinlechner, Ansgar Weltermann, Walter-Michael Halbmayer, Sibylle A. Kozek-Langenecker, Alexander Giurea, Franz Roithinger, Dietmar Fries, M. Gütl
Jazyk:	angličtina
Rok vydání:	2013
Předmět:	Ccarin clotting time medicine.medical_specialty Statement (logic) Psychological intervention Consensus Report Administration Oral Postoperative Hemorrhage Electronic Supplementary Material Antithrombins Dabigatran Prothrombincomplex concentrate Thrombin time rekombinanter Faktor VIIa Monitoring Intraoperative medicine Patient blood management Humans Ecarin clotting time Intensive care medicine Blood coagulation test Prothrombinkomplexkonzentrat Medicine(all) Dose-Response Relationship Drug business.industry Hämodialyse Thrombosis General Medicine Haemodialysis Austria Thrombinzeit Practice Guidelines as Topic beta-Alanine Recombinant factor VIIa Benzimidazoles Blood Coagulation Tests business medicine.drug
Zdroj:	Wiener Klinische Wochenschrift
ISSN:	1613-7671 0043-5325
Popis:	Summary The interdisciplinary group of experts has compiled a clinical guidance for manifest dabigatran-induced haemorrhage and envisaged invasive interventions on patients under dabigatran. It recommends an escalation of treatment measures as summarized in a pocket guide (see electronic supplementary material online and insert in the print issue). Electronic supplementary material The online version of this article (doi: 10.1007/s00508-013-0430-3) contains supplementary material, which is available to authorized users.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7360bfcb05af0119146f23da57d37644 http://europepmc.org/articles/PMC3838590 Zobrazit plný text záznamu Full text from SpringerLink